Systems Pharmacology Approach to Uncontrolled Pediatric Asthma

Status Completed

Clinical Trial Summary

Background: Asthma is a heterogeneous respiratory disease and the most common chronic disease in children. A small subset of children has continuous poor asthma control despite appropriate adherence to asthma medication. There is a clinical need to identify these children as early as possible to optimize treatment and/or to find therapeutic alternatives. Therefore, the "Systems Pharmacology approach to uncontrolled Pediatric Asthma" (SysPharmPediA) study was set up. Objective: To establish a cohort of pediatric moderate-to-severe uncontrolled and controlled patients with asthma in order to investigate pathophysiological mechanisms underlying uncontrolled moderate-to-severe asthma in children on maintenance treatment, using a multi-omics systems medicine approach. Methods: In this multicenter observational case-control study, moderate-to-severe asthmatic children (n=145, age 6-17 years), were included in specialized hospitals in four European countries (Netherlands, Germany, Spain and Slovenia). Recruited subjects were selected based on good asthma control (controlled asthmatics, n=54) or poor asthma control / recurrent exacerbations (uncontrolled asthmatics, n=91). Comprehensive details concerning demographics, current and past patient/family history and clinical characteristics were collected. In addition, systems-wide omics layers, including epi(genomics), transcriptomics, microbiome, proteomics and metabolomics will be evaluated from multiple collected, relatively non-invasive, samples of from the recruited individuals, such as: blood, feces, saliva, nasal swabs and exhaled breath. Follow-up visits were performed 6 and 12 months after inclusion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04865575
Study type	Observational
Source	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact
Status	Completed
Phase
Start date	January 12, 2018
Completion date	October 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05706571` - Child Patient End-of-Life Care Module	N/A
Not yet recruiting	`NCT05999032` - The Puerto Rico Asthma Integrated Response Program ("PR-AIR")	N/A
Not yet recruiting	`NCT06379607` - High Flow Nasal Cannula Rates in Pediatric Asthma	N/A
Completed	`NCT03933540` - Association Between Activity and PROMIS Pediatric Measures in Children With Asthma
Active, not recruiting	`NCT03842033` - Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients	N/A
Not yet recruiting	`NCT06321471` - AeviceMD for Pediatric Asthma Management	N/A
Not yet recruiting	`NCT05826561` - Developing a Childhood Asthma Risk Passive Digital Marker	N/A
Recruiting	`NCT05608668` - Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma	N/A
Completed	`NCT03814018` - Bronchoreversibility Test in Asthmatic Children and Correlation With Diagnostic Criteria Proposed by the GINA Guidelines
Recruiting	`NCT06112080` - Wearable Auscultation Device Validation in Children
Completed	`NCT01650844` - School-Based Telemedicine Enhanced Asthma Management	N/A
Completed	`NCT01326182` - Intervention for Depressed Latina Mothers of Children With Asthma	Phase 2
Recruiting	`NCT06223828` - Azithromycin for Critical Asthma - Pediatrics	Phase 2/Phase 3
Not yet recruiting	`NCT06278662` - Cohort Multiple Randomized Controlled Trial in Pediatric Asthma	N/A
Not yet recruiting	`NCT05945355` - Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)	N/A